<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Arterial occlusive disorders are a leading cause of human morbidity </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that ectopic expression of fibrinolytic proteins in platelets could be used to favorably alter the hemostatic balance at sites of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>To test our hypothesis, we directed murine urokinase-type plasminogen activator transgene expression to platelets using a platelet factor 4 promoter </plain></SENT>
<SENT sid="3" pm="."><plain>Urokinase was selectively expressed and stored in the platelets of these mice </plain></SENT>
<SENT sid="4" pm="."><plain>These transgenic mice had altered platelet biology and a <z:hpo ids='HP_0001892'>bleeding diathesis</z:hpo> similar to that seen in patients with Quebec <z:e sem="disease" ids="C0005818" disease_type="Disease or Syndrome" abbrv="">platelet disorder</z:e>, affirming the role of ectopic urokinase expression as the etiology of this <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">inherited disease</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>These mice were resistant to the development of occlusive carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> in the absence of systemic fibrinolysis and displayed rapid resolution of <z:e sem="disease" ids="C0034065" disease_type="Disease or Syndrome" abbrv="">pulmonary emboli</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Moreover, transfusion of urokinase-expressing platelets into <z:mp ids='MP_0002169'>wild-type</z:mp> mice prevented formation of occlusive arterial <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>These studies show the feasibility of delivering fibrinolytic agents to sites of incipient <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation through selective storage in platelets and offer a new strategy to prevent <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
</text></document>